Man, some people around here need their bipolar meds. Hypocrisy meds too. I remember being trashed on the yahoo board for selling in 2015 and buying Amazon, Sarepta and adding more Nektar. Bad moves... Honestly, it's like listening to a bunch of spoiled brats who aren't getting their way. It's an OTC stock with no cash and a CEO who has proven time and again to be less than stellar. What did you expect?
Guaranteed that if this went to .10 by days end, people would be posting of the unlimited potential.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links